F 0881
Implement a program that monitors antibiotic use.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review, the facility ' s nursing staff failed to update and maintain the facilities
Antibiotic Steward Program. (Log used to identify, track, and monitor infections and antibiotic use for the
residents.)
Residents Affected - Some
This failure had the potential to result in an inadequate antibiotic stewardship program to identify potential
inappropriate antibiotic use and antibiotic resistance.
Findings:
A review of Resident 2 ' s medical records indicated a urinalysis (UA-test for bacteria in the urine) was
ordered on 12/5/24. Laboratory results indicated a culture and sensitivity (C&S- test to determine the type
of bacteria and what antibiotic would treat the infection) which showed positive Escherichia coli.
(E.coli-bacteria).
A review of Resident 3 ' s medical records indicated a UA was ordered on 12/9/24. Laboratory results
indicated C&S positive for E.coli.
A review of Resident 4 ' s medical records indicated a UA was ordered on 12/10/24. Laboratory results
indicated C&S positive for E.coli.
A review of Resident 5 ' s medical records indicated a UA was ordered on 12/19/24. Laboratory results
indicated C&S positive for Citrobacter freundii.(bacteria)
A review of Resident 6 ' s medical records indicated a UA was ordered on 12/20/24. Laboratory results
indicated C&S positive for polymicrobic growth (multiple types of microorganism), probable skin
contamination per lab.
A review of Resident 7 ' s medical records indicated a UA was ordered on 12/22/24. Laboratory results
indicated C&S positive for E.coli.
A review of Resident 8 ' s medical records indicated a UA was ordered on 12/25/24. Laboratory results
indicated C&S indicated minimal growth.
A review of Resident 10 ' s ' medical records indicated a UA was ordered on 12/28/24. Laboratory results
indicated C&S positive for Staphylococcus aureus (bacteria).
A review of the facility ' s record, [Facility Name] Antibiotic Steward Program (ASP), dated December 2024,
indicated 15 residents were monitored for antibiotic use. The record indicated that each
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
555433
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555433
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/07/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Eastern Plumas Hospital- Portola Campus Dp/Snf
500 First Street
Portola, CA 96122
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0881
resident was to have 10 criteria monitored. The record indicated the following criteria were missing or
incomplete:
Level of Harm - Minimal harm
or potential for actual harm
Date: 3 out of 15 missing. (Residents 1,2,3)
Residents Affected - Some
Residents Medical Record number: 1 out of 15 missing. (Resident 3)
Dose and Duration: 2 out 15 missing (Resident 1,8) and 1 out of 15 was incomplete (Resident 3).
Start and Stop Date: 3 out of 15 missing (Residents 1,2,3) and 4 out 15 was incomplete. (Residents
1,3,4,10)
Clinical Indications Document signs and symptoms, date of culture: 7 out of 8 were missing date of culture.
(Residents 2,4,5,6,7,8,10).
Diagnosis: 1 out of 15 was missing. (Resident 2)
Date and initial of nurses that faxed to outside pharmacy: 2 out of 15 were missing (Residents 1,8) and 4
out of 15 were incomplete (Residents 3, 4, 5, 10).
Date that culture and sensitivity results faxed and to pharmacist: 7 out of 8 were missing. (Residents 2,4,
5,6,7,8,10).
During an interview on 1/7/25 at 2 pm with Infection Preventionist (IP), IP stated, the ASP was the log used
to track and investigate infections and antibiotic use for the residents. IP confirmed information on the ASP
was missing and incomplete. IP confirmed that all the information needed to be complete and updated on
the ASP log to analyze, monitor, and minimize the emergence and spread of antimicrobial resistance
(bacteria that becomes resistant to antibiotics due to overuse or use of the wrong antibiotic) and to ensure
safe and appropriate use of antimicrobial agents.
During an interview on 1/7/25 at 2:10 pm with Director of Nursing (DON), DON confirmed all the boxes
should be filled out and be updated by the nurses. DON confirmed information on the ASP was missing and
incomplete. DON confirmed that all the information needed to be complete and updated on the ASP log to
analyze, monitor, and minimize the emergence and spread of antimicrobial resistance and to ensure safe
and appropriate use of antimicrobial agents.
A review of facility Policy and Procedure (P&P) titled Infection Prevention and Control Plan (IPCP), dated
11/2024, indicated:
A. The facility shall develop and implement an IPCP with a goal of reducing risk of acquiring and
transmitting Healthcare-Associated Infections (HAIs) and to investigate and manage communicable (spread
from person to person) disease outbreaks.
B. Systems to provide access to information will be provided to support infection prevention and control
(IPC) activities.
C. Department managers and/or designees are responsible for monitoring employees and assuring
compliance with IPC P&Ps. Healthcare workers will adhere to the infection prevention policies.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555433
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555433
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/07/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Eastern Plumas Hospital- Portola Campus Dp/Snf
500 First Street
Portola, CA 96122
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0881
Level of Harm - Minimal harm
or potential for actual harm
D. IPC management functions are delegated to the Infection Preventionist (IP)/Infection Control Committee
(ICC) to investigate and follow up on clinical issues. Duties include:
1. Reviewing surveillance data monitoring for trends in infections, clusters, infections due to unusual
pathogens (an organism that can produce disease), or any occurrences of HAIs.
Residents Affected - Some
2. Reviews trends in antibiotic susceptibility/resistance (if the pathogen will be killed by an antibiotic or
resist it).
E. Prevention and/or risk reduction includes identifying and preventing HAIs by monitoring the appropriate
use of antibiotics and other antimicrobials (something that kills growth of bacteria, mold, fungi, and viruses).
F. Managing Critical Data and Information: Surveillance data will be analyzed appropriately and used to
monitor and improve infection control and healthcare outcomes.
A review of facility P&P titled Antimicrobial Stewardship Program (ASP), dated 9/2024, indicated:
A. The Antimicrobial Stewardship Committee has been formed to evaluate, report, and monitor the use of
antimicrobial agents. Members include a Medical Director, Clinical Pharmacist, Microbiologist,
representatives from Quality/Performance Improvement and other vested practitioners, including the Chief
Nursing Officer.
B. The facility maintains an ASP to minimize the emergence and spread of antimicrobial resistance and to
ensure safe and appropriate use of antimicrobial agents.
C. The ASP interventions will include conducting retrospective (looking back) and prospective (looking
forward) antimicrobial use evaluations and review/track trends in microbial resistance/susceptibility.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555433
If continuation sheet
Page 3 of 3